Substances & reference · openFDA

Historical FDA documents

FDA press releases and papers from the agency's history, as full text. 8,858 records; openFDA updated it 2026-10-02. About this dataset

Newest records

  • FDA STATEMENT For Immediate Release: April 3, 2014 FDA Commissioner Margaret A. Hamburg Statement on Prescrip…

    FDA STATEMENT For Immediate Release: April 3, 2014 FDA Commissioner Margaret A. Hamburg Statement on Prescription Opioid Abuse For more than a decade, the U.S. Food and Drug Administration has been working to address th…

    Press release2 pages
  • For Immediate Release: March 20, 2014

    FDA NEWS RELEASE For Immediate Release: March 20, 2014 Espafiol FDA approves first implantable hearing device for adults with a certain kind of hearing loss The U.S. Food and Drug Administration today approved the first…

    Press release2 pages
  • For Immediate Release: July 29, 2014

    FDA Statement For Immediate Release: July 29, 2014 FDA Commissioner Margaret A. Hamburg’s Statement on the Surgeon General’s Call to Action to Prevent Skin Cancer Espafiol Each year, thousands of Americans are diagnosed…

    Press release2 pages
  • For Immediate Release: April 17, 2014

    FDA NEWS RELEASE For Immediate Release: April 17, 2014 FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids Procedure poses risk of spreading undetected cancerous tissue in wo…

    Press release3 pages
  • FDA NEWS RELEASE For Immediate Release: Jan. 8, 2014

    FDA NEWS RELEASE For Immediate Release: Jan. 8, 2014 En Espafiol FDA approves Farxiga to treat type 2 diabetes The U.S. Food and Drug Administration today approved Farxiga (dapaglifozin) tablets to improve glycemic contr…

    Press release2 pages
  • For Immediate Release - December 15, 2014

    FDA News Release For Immediate Release - December 15, 2014 FDA grants CLIA waiver expanding the availability of rapid screening test for syphilis Espafiol The U.S. Food and Drug Administration today announced that it gra…

    Press release3 pages
  • For Immediate Release - September 5, 2014

    FDA News Release For Immediate Release - September 5, 2014 FDA allows marketing of the first test to assess risk of developing acute kidney injury Today the U.S. Food and Drug Administration allowed marketing of the Nep…

    Press release2 pages
  • For Immediate Release: Feb. 5, 2014

    FDA NEWS RELEASE For Immediate Release: Feb. 5, 2014 FDA Commissioner Hamburg travels to India Visit to highlight importance of ongoing collaboration on food and drug programs Today, the U.S. Food and Drug Administratio…

    Press release1 pages
  • For Immediate Release: April 10, 2014

    FDA NEWS RELEASE For Immediate Release: April 10, 2014 Espafiol FDA approves expanded indication for certain pacemakers and defibrillators used to treat heart failure The U.S. Food and Drug Administration today approved…

    Press release2 pages
  • For Immediate Release: May 9, 2014

    FDA NEWS RELEASE For Immediate Release: May 9, 2014 FDA allows marketing of first prosthetic arm that translates signals from person’s muscles to perform complex tasks The U.S. Food and Drug Administration (FDA) today a…

    Press release2 pages
  • For Immediate Release - November 24, 2014

    FDA News Release For Immediate Release - November 24, 2014 FDA warns against using Iaparoscopic power morcellators to treat uterine fibroids Agency recommends adding important safety information to product labels Today,…

    Press release2 pages
  • For Immediate Release - October 10, 2014

    FDA News Release For Immediate Release - October 10, 2014 FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy The U.S. Food and Drug Administration today approved Akynzeo (netupitant and pal…

    Press release1 pages
  • For Immediate Release - July 24, 2014

    FDA News Release For Immediate Release - July 24, 2014 Espafiol The United States and Mexico sign statement of intent to strengthen produce safety The U.S. Food and Drug Administration and the government of Mexico’s Nati…

    Press release2 pages
  • For Immediate Release - June 20, 2014

    FDA News Release For Immediate Release - June 20, 2014 FDA approves Sivextro to treat skin infections The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to tre…

    Press release2 pages
  • FDA NEWS RELEASE For Immediate Release: March 17, 2014

    FDA NEWS RELEASE For Immediate Release: March 17, 2014 Some lots of Simply Lite brand dark chocolate recalled Testing reveals significant amounts of milk protein, potentially putting those with milk allergy at risk Fast…

    Press release2 pages
  • For Immediate Release - October 15, 2014

    FDA News Release For Immediate Release - October 15, 2014 FDA approves Ofev to treat idiopathic pulmonary fibrosis The U.S. Food and Drug Administration today approved Ofev (nintedanib) for the treatment of idiopathic p…

    Press release2 pages
  • For Immediate Release - July 9, 2014

    FDA News Release For Immediate Release - July 9, 2014 United States enters consent decree with New York dietary supplement manufacturer Repeated failure to follow current good manufacturing practice prompts government a…

    Press release2 pages
  • For Immediate Release - December 4, 2014

    FDA News Release For Immediate Release - December 4, 2014 FDA resolves criminal and civil actions against Main Street Family Pharmacy Main Street Family Pharmacy, LLC, a compounding pharmacy in Newbern, Tennessee, and t…

    Press release2 pages
  • For Immediate Release - August 6, 2014

    FDA News Release For Immediate Release - August 6, 2014 FDA approves Orbactiv to treat skin infections Third new antibacterial drug approved for this use this year The U.S. Food and Drug Administration today approved Or…

    Press release2 pages
  • For Immediate Release: April 2, 2014

    FDA NEWS RELEASE For Immediate Release: April 2, 2014 Espafiol FDA approves first sublingual allergen extract for the treatment of certain grass pollen allergies The U.S. Food and Drug Administration recently approved Or…

    Press release2 pages
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.